S&P Global [SPGI] vs CME [CME] Detailed Stock Comparison
S&P Global
NYSE
Loading...
CME
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: S&P Global wins in 7 metrics, CME wins in 13 metrics, with 0 ties. CME appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | S&P Global | CME | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 42.37 | 26.52 | CME |
| Price-to-Book Ratio | 5.04 | 3.55 | CME |
| Debt-to-Equity Ratio | 31.65 | 13.60 | CME |
| PEG Ratio | 5.07 | 1.70 | CME |
| EV/EBITDA | 25.21 | 22.08 | CME |
| Profit Margin (TTM) | 27.29% | 58.59% | CME |
| Operating Margin (TTM) | 42.69% | 66.87% | CME |
| EBITDA Margin (TTM) | 42.69% | 66.87% | CME |
| Return on Equity | 11.29% | 13.61% | CME |
| Return on Assets (TTM) | 6.26% | 1.74% | S&P Global |
| Free Cash Flow (TTM) | $5.57B | $3.60B | S&P Global |
| Dividend Yield | 0.55% | 4.30% | CME |
| 1-Year Return | 10.76% | 31.12% | CME |
| Price-to-Sales Ratio (TTM) | 11.45 | 15.35 | S&P Global |
| Enterprise Value | $183.02B | $100.39B | S&P Global |
| EV/Revenue Ratio | 12.45 | 15.61 | S&P Global |
| Gross Profit Margin (TTM) | 70.20% | 86.90% | CME |
| Revenue per Share (TTM) | $48 | $18 | S&P Global |
| Earnings per Share (Diluted) | $13.01 | $10.33 | S&P Global |
| Beta (Stock Volatility) | 1.19 | 0.46 | CME |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
S&P Global vs CME Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| S&P Global | 0.47% | -0.83% | 6.19% | 5.75% | 2.16% | 11.89% |
| CME | 1.10% | -1.59% | -1.28% | -2.32% | 8.27% | 16.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| S&P Global | 10.76% | 52.29% | 51.14% | 457.50% | 1,855.66% | 1,058.44% |
| CME | 31.12% | 38.27% | 53.36% | 186.93% | 428.70% | 404.63% |
Performance & Financial Health Analysis: S&P Global vs CME
| Metric | SPGI | CME |
|---|---|---|
| Market Information | ||
| Market Cap | $168.28B | $98.72B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,049,030 | 1,887,200 |
| 90 Day Avg. Volume | 1,085,040 | 2,111,473 |
| Last Close | $557.03 | $274.47 |
| 52 Week Range | $427.14 - $579.05 | $206.44 - $290.79 |
| % from 52W High | -3.80% | -5.61% |
| All-Time High | $579.05 (Aug 14, 2025) | $290.79 (Jun 02, 2025) |
| % from All-Time High | -3.80% | -5.61% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.10% |
| Quarterly Earnings Growth | 0.06% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.27% | 0.59% |
| Operating Margin (TTM) | 0.43% | 0.67% |
| Return on Equity (TTM) | 0.11% | 0.14% |
| Debt to Equity (MRQ) | 31.65 | 13.60 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $109.37 | $77.13 |
| Cash per Share (MRQ) | $6.05 | $5.82 |
| Operating Cash Flow (TTM) | $5.58B | $4.20B |
| Levered Free Cash Flow (TTM) | $4.93B | $2.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.55% | 4.30% |
| Last 12-Month Dividend | $2.78 | $11.85 |
Valuation & Enterprise Metrics Analysis: S&P Global vs CME
| Metric | SPGI | CME |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 42.37 | 26.52 |
| Forward P/E | 32.79 | 26.41 |
| PEG Ratio | 5.07 | 1.70 |
| Price to Sales (TTM) | 11.45 | 15.35 |
| Price to Book (MRQ) | 5.04 | 3.55 |
| Market Capitalization | ||
| Market Capitalization | $168.28B | $98.72B |
| Enterprise Value | $183.02B | $100.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.45 | 15.61 |
| Enterprise to EBITDA | 25.21 | 22.08 |
| Risk & Other Metrics | ||
| Beta | 1.19 | 0.46 |
| Book Value per Share (MRQ) | $109.37 | $77.13 |
Financial Statements Comparison: S&P Global vs CME
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SPGI | CME |
|---|---|---|
| Revenue/Sales | $3.78B | $1.64B |
| Cost of Goods Sold | $1.15B | $206.70M |
| Gross Profit | $2.62B | $1.44B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $1.57B | $1.11B |
| EBITDA | $1.88B | $476.30M |
| Pre-Tax Income | $1.50B | $1.24B |
| Income Tax | $325.00M | $288.60M |
| Net Income (Profit) | $1.17B | $956.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SPGI | CME |
|---|---|---|
| Cash & Equivalents | $1.47B | $1.41B |
| Total Current Assets | $5.34B | $123.45B |
| Total Current Liabilities | $5.92B | $121.42B |
| Long-Term Debt | $11.91B | $3.42B |
| Total Shareholders Equity | $37.73B | $27.03B |
| Retained Earnings | $21.80B | $4.69B |
| Property, Plant & Equipment | $1.50B | $371.20M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SPGI | CME |
|---|---|---|
| Operating Cash Flow | $708.00M | $838.30M |
| Capital Expenditures | N/A | $-14.20M |
| Free Cash Flow | $910.00M | $1.10B |
| Debt Repayment | $-4.00M | $-750.00M |
| Common Stock Repurchase | $-650.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SPGI | CME |
|---|---|---|
| Shares Short | 2.97M | 5.42M |
| Short Ratio | 2.91 | 2.53 |
| Short % of Float | 0.01% | 0.02% |
| Average Daily Volume (10 Day) | 1,049,030 | 1,887,200 |
| Average Daily Volume (90 Day) | 1,085,040 | 2,111,473 |
| Shares Outstanding | 307.80M | 359.61M |
| Float Shares | 304.63M | 358.78M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.90% | 0.92% |
Dividend Analysis & Yield Comparison: S&P Global vs CME
| Metric | SPGI | CME |
|---|---|---|
| Last 12-Month Dividend | $2.78 | $11.85 |
| Last 12-Month Dividend Yield | 0.55% | 4.30% |
| 3-Year Avg Annual Dividend | $3.00 | $10.10 |
| 3-Year Avg Dividend Yield | 0.21% | 0.91% |
| 3-Year Total Dividends | $9.00 | $30.30 |
| Ex-Dividend Date | Feb 26, 2025 | Sep 09, 2025 |